|
1
|
Todi S: Sepsis: New horizons. Ind J Crit
Care Med. 14:1–2. 2010. View Article : Google Scholar
|
|
2
|
Angus DC, Linde-Zwirble WT, Lidicker J,
Clermont G, Carcillo J and Pinsky MR: Epidemiology of severe sepsis
in the United States: Analysis of incidence, outcome and associated
costs of care. Crit Care Med. 29:1303–1310. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Martin GS, Mannino DM, Eaton S and Moss M:
The epidemiology of sepsis in the United States from 1979 through
2000. New Eng J Med. 348:1546–1554. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Carvalho PR and Trotta Ede A: Advances in
sepsis diagnosis and treatment. J Pediatr (Rio J). 79(Suppl 2):
S195–S204. 2003. View Article : Google Scholar
|
|
5
|
Marra MN, Thornton MB, Snable JL, Wilde CG
and Scott RW: Endotoxin-binding and -neutralizing properties of
recombinant bactericidal/permeability-increasing protein and
monoclonal antibodies HA-1A and E5. Crit Care Med. 22:559–565.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cohen J: Adjunctive therapy in sepsis: A
critical analysis of the clinical trial programme. Brit Med Bull.
55:212–225. 1999. View Article : Google Scholar
|
|
7
|
Riedemann NC, Guo RF and Ward PA: The
enigma of sepsis. J Clin Invest. 112:460–467. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bone RC, Fisher CJ Jr, Clemmer TP, Slotman
GJ, Metz CA and Balk RA: Sepsis syndrome: A valid clinical entity.
Methylprednisolone severe sepsis study group. Crit Care Med.
17:389–393. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kumar A, Roberts D, Wood KE, Light B,
Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L,
et al: Duration of hypotension before initiation of effective
antimicrobial therapy is the critical determinant of survival in
human septic shock. Crit Care Med. 34:1589–1596. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zambon M, Ceola M, Almeida-de-Castro R,
Gullo A and Vincent JL: Implementation of the surviving sepsis
campaign guidelines for severe sepsis and septic shock: We could go
faster. J Crit Care. 23:455–460. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schröder J, Kahlke V, Staubach KH, Zabel P
and Stüber F: Gender differences in human sepsis. Arch Surg.
133:1200–1205. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pietropaoli AP, Glance LG, Oakes D and
Fisher SG: Gender differences in mortality in patients with severe
sepsis and septic shock. Gender Med. 7:422–437. 2010. View Article : Google Scholar
|
|
13
|
Angstwurm MW, Gaertner R and Schopohl J:
Outcome in elderly patients with severe infection is influenced by
sex hormones but not gender. Crit Care Med. 33:2786–2793. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schröder J, Kahlke V, Book M and Stüber F:
Gender differences in sepsis: Genetically determined? Shock.
14:307–310; discussion 310–313. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baghel K, Srivastava RN, Chandra A, Raj S,
Goel SK, Pant AB and Agrawal J: Tumor necrosis factor-β Nco1
polymorphism and susceptibility to sepsis following major elective
surgery. Surg Infect (Larchmt). 15:213–20. 2014. View Article : Google Scholar
|
|
16
|
Kalenka A, Feldmann RE Jr, Otero K, Maurer
MH, Waschke KF and Fiedler F: Changes in the serum proteome of
patients with sepsis and septic shock. Anesth Analg. 103:1522–1526.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Su L, Cao L, Zhou R, Jiang Z, Xiao K, Kong
W, Wang H, Deng J, Wen B, Tan F, et al: Identification of novel
biomarkers for sepsis prognosis via urinary proteomic analysis
using iTRAQ labeling and 2D-LC-MS/MS. PloS One. 8:e542372013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Knaus WA, Draper EA, Wagner DP and
Zimmerman JE: APACHE II: A severity of disease classification
system. Crit Care Med. 13:818–829. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Markgraf R, Deutschinoff G, Pientka L and
Scholten T: Comparison of acute physiology and chronic health
evaluations II and III and simplified acute physiology score II: A
prospective cohort study evaluating these methods to predict
outcome in a German interdisciplinary intensive care unit. Crit
Care Med. 28:26–33. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wiersinga WJ, Leopold SJ, Cranendonk DR
and van der Poll T: Host innate immune responses to sepsis.
Virulence. 5:36–44. 2014. View Article : Google Scholar :
|
|
21
|
Becker KL, Snider R and Nylen ES:
Procalcitonin assay in systemic inflammation, infection and sepsis:
Clinical utility and limitations. Crit Care Med. 36:941–452. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sakr Y, Sponholz C, Tuche F, Brunkhorst F
and Reinhart K: The role of procalcitonin in febrile neutropenic
patients: Review of the literature. Infection. 36:396–407. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim KE and Han JY: Evaluation of the
clinical performance of an automated procalcitonin assay for the
quantitative detection of bloodstream infection. Korean J Lab Med.
30:153–159. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pettilü V, Hynninen M, Takkunen O, Kuusela
P and Valtonen M: Predictive value of procalcitonin and interleukin
6 in critically ill patients with suspected sepsis. Intensive Care
Med. 28:1220–1225. 2002. View Article : Google Scholar
|
|
25
|
Ruiz-Alvarez MJ, Garcia-Valdecasas S, De
Pablo R, Sanchez Garcia M, Coca C, Groeneveld TW, Roos A, Daha MR
and Arribas I: Diagnostic efficacy and prognostic value of serum
procalcitonin concentration in patients with suspected sepsis. J
Intens Care Med. 24:63–71. 2009. View Article : Google Scholar
|
|
26
|
Fischer CL, Gill C, Forrester MG and
Nakamura R: Quantitation of 'acute-phase proteins' postoperatively.
Value in detection and monitoring of complications. Am J Clin
Pathol. 66:840–846. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gruys E, Toussaint MJ, Niewold TA and
Koopmans SJ: Acute phase reaction and acute phase proteins. J
Zhejiang Univ Sci B. 6:1045–1556. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hari-Dass R, Shah C, Meyer DJ and Raynes
JG: Serum amyloid A protein binds to outer membrane protein A of
gram-negative bacteria. J Biol Chem. 280:18562–18567. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Larson MA, Weber A, Weber AT and McDonald
TL: Differential expression and secretion of bovine serum amyloid
A3 (SAA3) by mammary epithelial cells stimulated with prolactin or
lipopolysaccharide. Vet Immunol Immunop. 107:255–264. 2005.
View Article : Google Scholar
|
|
30
|
Cicarelli LM, Perroni AG, Zugaib M, de
Albuquerque PB and Campa A: Maternal and cord blood levels of serum
amyloid A, C-reactive protein, tumor necrosis factor-alpha,
interleukin-1beta and interleukin-8 during and after delivery.
Mediat Inflamm. 2005:96–100. 2005. View Article : Google Scholar
|
|
31
|
Gabay C and Kushner I: Acute-phase
proteins and other systemic responses to inflammation. N Eng J Med.
340:448–454. 1999. View Article : Google Scholar
|
|
32
|
Weimer HE and Winzler RJ: Comparative
study of orosomucoid preparations from sera of six species of
mammals. Proc Soc Exp Biol Med. 90:458–60. 1955. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Whicher JT: BCR/IFCC reference material
for plasma proteins (CRM 470). Community bureau of reference.
International Federation of Clinical Chemistry. Clin Biochem.
31:459–465. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dinarello CA: Cytokines as mediators in
the pathogenesis of septic shock. Curr Top Microbiol Immunol.
216:133–165. 1996.PubMed/NCBI
|
|
35
|
Henry OF, Blacher J, Verdavaine J,
Duviquet M and Safar ME: Alpha 1-acid glycoprotein is an
independent predictor of in-hospital death in the elderly. Age
Ageing. 32:37–42. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Barroso-Sousa R, Lobo RR, Mendonça PR,
Memória RR, Spiller F, Cunha FQ and Pazin-Filho A: Decreased levels
of alpha-1-acid glycoprotein are related to the mortality of septic
patients in the emergency department. Clinics (Sao Paulo).
68:1134–1139. 2013. View Article : Google Scholar
|
|
37
|
Langlois MR and Delanghe JR: Biological
and clinical significance of haptoglobin polymorphism in humans.
Clin Chem. 42:1589–600. 1996.PubMed/NCBI
|
|
38
|
Cynober L, Prugnaud O, Lioret N, Duchemin
C, Saizy R and Giboudeau J: Serum transthyretin levels in patients
with burn injury. Surgery. 109:640–644. 1991.PubMed/NCBI
|
|
39
|
Payen D, Lukaszewicz AC, Belikova I,
Faivre V, Gelin C, Russwurm S, Launay JM and Sevenet N: Gene
profiling in human blood leucocytes during recovery from septic
shock. Intens Care Med. 34:1371–1376. 2008. View Article : Google Scholar
|
|
40
|
Szallasi Z: Genetic network analysis in
light of massively parallel biological data acquisition. Pac Symp
Biocomput. 5–16. 1999.PubMed/NCBI
|
|
41
|
Cho RJ, Campbell MJ, Winzeler EA,
Steinmetz L, Conway A, Wodicka L, Wolfsberg TG, Gabrielian AE,
Landsman D, Lockhart DJ and Davis RW: A genome-wide transcriptional
analysis of the mitotic cell cycle. Mol Cell. 2:65–73. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lichtinghagen R, Musholt PB, Lein M, Römer
A, Rudolph B, Kristiansen G, Hauptmann S, Schnorr D, Loening SA and
Jung K: Different mRNA and protein expression of matrix
metalloproteinases 2 and 9 and tissue inhibitor of
metalloproteinases 1 in benign and malignant prostate tissue. Eur
Urol. 42:398–406. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen G, Gharib TG, Huang CC, Taylor JM,
Misek DE, Kardia SL, Giordano TJ, Iannettoni MD, Orringer MB,
Hanash SM and Beer DG: Discordant protein and mRNA expression in
lung adenocarcinomas. Mol Cell Proteomics. 1:304–313. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Glickman MH and Ciechanover A: The
ubiquitin-proteasome proteolytic pathway: Destruction for the sake
of construction. Physiol Rev. 82:373–428. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pratt JM, Petty J, Riba-Garcia I,
Robertson DH, Gaskell SJ, Oliver SG and Beynon RJ: Dynamics of
protein turnover, a missing dimension in proteomics. Mol Cell
Proteomics. 1:579–591. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Langlois MR and Delanghe JR: Biological
and clinical significance of haptoglobin polymorphism in humans.
Clin Chem. 42:1589–1600. 1996.PubMed/NCBI
|
|
47
|
Gogos CA, Drosou E, Bassaris HP and
Skoutelis A: Pro-versus anti-inflammatory cytokine profile in
patients with severe Sepsis: A marker for prognosis and future
therapeutic options. J Infect Dis. 181:176–180. 2000. View Article : Google Scholar
|
|
48
|
Wang CH, Gee MJ, Yang C and Su YC: A new
model for outcome prediction in intra-abdominal sepsis by the
linear discriminant function analysis of IL-6 and IL-10 at
different heart rates. J Surg Res. 132:46–51. 2006. View Article : Google Scholar
|
|
49
|
Acosta C and Davies A: Bacterial
lipopolysaccharide regulates nociceptin expression in sensory
neurons. J Neurosci Res. 86:1077–1086. 2008. View Article : Google Scholar
|
|
50
|
Andoh T, Itoh M and Kuraishi Y: Nociceptin
gene expression in rat dorsal root ganglia induced by peripheral
inflammation. Neuroreport. 8:2793–2796. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Itoh M, Takasaki I, Andoh T, Nojima H,
Tominaga M and Kuraishi Y: Induction by carrageenan inflammation of
prepronociceptin mRNA in VR1-immunoreactive neurons in rat dorsal
root ganglia. Neurosci Res. 40:227–233. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Williams JP, Thompson JP, Young SP, Gold
SJ, McDonald J, Rowbotham DJ and Lambert DG: Nociceptin and
urotensin-II concentrations in critically ill patients with sepsis.
Bri J Anaesth. 100:810–814. 2008. View Article : Google Scholar
|
|
53
|
Dellinger RP, Levy M, Rhodes A, Annane D,
Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke
R, et al: Surviving sepsis campaign: International guidelines for
management of severe sepsis and septic shock, 2012. Intens Care
Med. 39:165–228. 2012, 2013. View Article : Google Scholar
|
